The study, published in Nature Medicine, also concludes that those individuals homozygous for APOE4 also develop the disease earlier than those with other variants of the APOE gene. These findings ...
CB1 Receptor Signaling Specific Inhibitors (CB1-SSi), mimics a natural defense mechanism of the brain to counteract the hyperactivity of this receptor. At the same time, the function of the APOE4 ...
But with several small-molecule cholinesterase inhibitors in late-stage trials ... noncarriers of the apolipoprotein E4 (ApoE4) gene. Post-hoc analyses showed these patients had improved ...